Topical capsaicin for chronic neuropathic pain in adults
Información
- DOI:
- https://doi.org/10.1002/14651858.CD007393.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Dolor y cuidados paliativos
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
SD and RL carried out searches for studies, data extraction and analyses. RAM was involved with analysis and HJM acted as arbitrator. All authors were involved with writing the review. SD will be responsible for the update of this review.
Sources of support
Internal sources
-
Oxford Pain Research Funds, UK.
External sources
-
NHS Cochrane Collaboration Programme Grant Scheme, UK.
-
NIHR Biomedical Research Centre Programme, UK.
Declarations of interest
RAM, HJM, SD have received research support from charities, government and industry sources at various times. RAM and HJM have consulted for various pharmaceutical companies and have received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Jan 13 | Topical capsaicin (high concentration) for chronic neuropathic pain in adults | Review | Sheena Derry, Andrew SC Rice, Peter Cole, Toni Tan, R Andrew Moore | |
| 2013 Feb 28 | Topical capsaicin (high concentration) for chronic neuropathic pain in adults | Review | Sheena Derry, Andrew S C Rice, Peter Cole, Toni Tan, R Andrew Moore | |
| 2009 Oct 07 | Topical capsaicin for chronic neuropathic pain in adults | Review | Sheena Derry, Rosalind Lloyd, R Andrew Moore, Henry J McQuay | |
| 2009 Jul 08 | Topical capsaicin for chronic neuropathic pain in adults | Protocol | Sheena Derry, R Andrew Moore, Henry J McQuay, Rosalind Lloyd | |
Differences between protocol and review
The protocol specified that treatment should be applied at least three times daily, based on published studies known to the authors. Since then, new studies using a single high dose capsaicin patch that are of high quality and include large numbers of participants, have been published. It was felt that these studies should be included and analysed separately because of their different study design, rather than be excluded because they did not satisfy the original inclusion criteria.
